Skip to main content

Regulatory Authorities and Reimbursement Mechanisms

Buy Article:

$24.00 plus tax (Refund Policy)

This chapter looks at the role of regulators and reimbursement systems in facilitating the uptake of pharmacogenetics by health‐care systems. Regulators and coverage policies will be strong factors in the rate of diffusion of pharmacogenetics. Reimbursement policies and cost‐containment strategies for drug and test‐use policies and clinical guidelines will be very important. The challenges for payers and the trade‐offs they may have to make are also considered.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Document Type: Review Article

Publication date: 2009-11-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more